Shots: ThermoFisher to acquire PPD for $47.50/share making a total purchase price of $17.4B along with ~$3.5B of net debt with a premium of ~24% to the closing price of PPD’s common stock as of Apr 13, 2021. The transaction is expected to be completed by the end of 2021 The acquisition expands ThermoFisher’s service […]Read More
Shots: The company has launched the first virtual clinic to guide patients with chronic conditions and helps to improve health and behavior via tracking tools & informational guides for weight management, daily activity levels and more Omada’s platform uses AI to analyze movements and range of motion via video and offers physical therapy sessions, wearable […]Read More
Shots: Medtronic launches a new insulin infusion set that can be worn for up to 7days. The infusion set is compatible with all MiniMed 600 and 700 series insulin pumps The extended infusion set utilizes advanced materials that help in reducing insulin preservative loss and maintains its flow & stability. The new tubing connector improves […]Read More
Shots: The companies collaborated to develop a custom version of AnemoCheck Mobile to measure Hgb levels in patients with anemia of CKD AnemoCheck app can measure Hgb levels using a single photo of a user’s fingernail applying an algorithm based on the pallor of a patient’s nailbed without the need to draw blood and allow […]Read More
Shots: The companies launched the Mallya smart insulin pen device in France to support patients with diabetes. The smart insulin pen is available in pharmacies and is compatible with any disposable insulin pens The device collects and transfers insulin data with 100% accuracy and is rechargeable via its USB port. Mallya automatically collects insulin data […]Read More
Shots: Avantor to acquire Ritter and its affiliates in an all-cash transaction with an up front equity purchase price of ~ $1.06B along with additional payments following the achievement of milestones. The transaction is expected to be completed in Q3’21 The acquisition expands Avantor’s offering for diagnostic and drug discovery workflows The acquisition integrates Ritter’s […]Read More
Shots: DiaSorin to acquire Luminex for $37.00/ share in an all-cash transaction, with 23% premium based on closing stock price of Luminex on 24 Feb, 2021, making a total equity value of $1.8B The acquisition will boost DiaSorin’s presence in the molecular diagnostics space in the US with the addition of Luminex’s molecular diagnostics multiplexing […]Read More
Shots: Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21 The acquisition will accelerate Hologic’s global footprints by enabling it to expand into the large, fast-growing acute care adjacency with a near-patient testing solution that offers ease of […]Read More
Shots: Menicon to develop and manufacture contact lenses to help manage the progression of myopia in children. J&J Vision will focus on expanding the availability of these lenses across the globe The collaboration will combine the expertise of both the companies and allow J&J to bring a portfolio of differentiated products that helps in managing […]Read More
Shots: Roche launches Elecsys EBV immunoassay panel in countries accepting the CE mark. The Elecsys EBV panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV VCA IgG, and Elecsys EBV EBNA IgG to detect Abs specific for the infection stage The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
